Lighthouse Group* (LGT): Organic growth accelerating (CORP) | ANGLE* (AGL): Liquid biopsy play with early traction (CORP) | Alumasc (ALU): Interims in line, dividend stronger than forecast (BUY) | OptiBiotix* (OPTI): TATA scale up & manufacturing agreement (CORP) | Vipera* (VIP): H1 sales growth and global expansion (CORP) | Mattioli Woods (MTW): Up with events (HOLD)
05 Sep 2017
Morning Note
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Morning Note
- Published:
05 Sep 2017 -
Author:
David Buxton | Mark Brewer | Cavendish Research -
Pages:
8
Lighthouse Group* (LGT): Organic growth accelerating (CORP) | ANGLE* (AGL): Liquid biopsy play with early traction (CORP) | Alumasc (ALU): Interims in line, dividend stronger than forecast (BUY) | OptiBiotix* (OPTI): TATA scale up & manufacturing agreement (CORP) | Vipera* (VIP): H1 sales growth and global expansion (CORP) | Mattioli Woods (MTW): Up with events (HOLD)